MSF's publications are an expression of our belief in the principle of témoignage, or bearing witness, and the belief that we are accountable to those we work for and with. Sharing news about our activities and reflecting on them, offering critiques when necessary, are therefore crucial aspects of our work.

View and download these publications below.

To view the U.S. Annual Reports or International Activity Reports, please visit the Annual Reports page.

Country/Region

October 04, 2017

In 2017, nearly half of MSF's patients in Serbia were under 18; almost all of them were refugees and asylum-seekers who were traveling unaccompanied or became separated from their parents. Minors are supposed to be protected by the system, but many of these young people report violent abuse by European Union border authorities and police.

July 05, 2017

Two days ahead of the G20 summit in Germany, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) and the Stop TB Partnership released a report that shows countries are lagging behind in tackling tuberculosis (TB), introducing the best diagnostic devices, and implementing globally-recommended policies. The third edition of the “Out of Step” report reviews TB policies and practices in 29[1] countries–which account for 82 percent of the global TB burden–and shows that countries can do much more to prevent, diagnose, and treat people affected by TB.

September 19, 2016

With winter starting to factor into people's thoughts, prospects seem grim for many of the migrants living in the notorious "Jungle" camp in Calais, in northern France. The French government has vowed to shut the camp down once and for all. Another barrier—a 13-foot-high, half-mile-long wall—appears set to go up. And just this week, Calais residents held demonstrations and set up roadblocks demanding that the camp be razed.

Even though assistance to the camp appears to have thinned, people are still making their way there.

February 24, 2016

International medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today expressed great concern at the high price announced for the new tuberculosis (TB) drug delamanid. Japanese pharmaceutical company Otsuka said that it would make delamanid available to some developing countries at a price of $1,700 per treatment course.

December 13, 2013

As Syrian refugees increasingly head towards Bulgaria, MSF is working to provide aid and assist the overstretched Bulgarian authorities.

November 22, 2013

Hundreds of refugees are living in appalling conditions in Bulgarian reception centers where there is a disastrous lack of medical care.

October 04, 2017

In 2017, nearly half of MSF's patients in Serbia were under 18; almost all of them were refugees and asylum-seekers who were traveling unaccompanied or became separated from their parents. Minors are supposed to be protected by the system, but many of these young people report violent abuse by European Union border authorities and police.

July 05, 2017

Two days ahead of the G20 summit in Germany, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) and the Stop TB Partnership released a report that shows countries are lagging behind in tackling tuberculosis (TB), introducing the best diagnostic devices, and implementing globally-recommended policies. The third edition of the “Out of Step” report reviews TB policies and practices in 29[1] countries–which account for 82 percent of the global TB burden–and shows that countries can do much more to prevent, diagnose, and treat people affected by TB.

September 19, 2016

With winter starting to factor into people's thoughts, prospects seem grim for many of the migrants living in the notorious "Jungle" camp in Calais, in northern France. The French government has vowed to shut the camp down once and for all. Another barrier—a 13-foot-high, half-mile-long wall—appears set to go up. And just this week, Calais residents held demonstrations and set up roadblocks demanding that the camp be razed.

Even though assistance to the camp appears to have thinned, people are still making their way there.

February 24, 2016

International medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today expressed great concern at the high price announced for the new tuberculosis (TB) drug delamanid. Japanese pharmaceutical company Otsuka said that it would make delamanid available to some developing countries at a price of $1,700 per treatment course.

December 13, 2013

As Syrian refugees increasingly head towards Bulgaria, MSF is working to provide aid and assist the overstretched Bulgarian authorities.

November 22, 2013

Hundreds of refugees are living in appalling conditions in Bulgarian reception centers where there is a disastrous lack of medical care.